Loading organizations...
Wolverine Venture Fund operates as the world's first student-run venture capital fund, offering a unique platform for experiential learning within the University of Michigan. It actively manages a multi-million dollar portfolio, deploying capital into early-stage companies, primarily focusing on Series A and Series B investment rounds. This initiative provides graduate students with practical, hands-on experience across the entire venture investing process, from deal sourcing and initial analysis to due diligence and portfolio management.
The fund was established in 1997, born from the innovative insight to provide students with a real-world venture capital experience. It began with a $2 million foundational gift, enabling MBA and other graduate students, including those from life sciences and biomedical engineering disciplines, to serve as partners. This structure ensures that future leaders gain invaluable practical knowledge in identifying and evaluating high-growth potential businesses.
Wolverine Venture Fund supports nascent companies by providing essential capital resources and strategic guidance, fostering their development in critical growth phases. Concurrently, it cultivates the next generation of venture capitalists, equipping students with the skills and insights necessary for successful careers in the investment ecosystem. The fund envisions a future where its alumni continue to shape the entrepreneurial landscape while its portfolio companies thrive.
Wolverine Venture Fund has 3 tracked investments across 2 companies. The latest tracked deal is $21.0M Series B in NeuMoDx Molecular in April 2014.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2014 | NeuMoDx Molecular | $21.0M Series B | — | Arboretum Ventures, Baird Capital, Venture Investors |
| Feb 10, 2014 | ArborMetrix | $1.3M Series B | RPM Ventures | Arboretum Ventures, Adrian Fortino, Chris Rizik |
| Jul 16, 2013 | ArborMetrix | $7.0M Series B | Tony Grover | Paul Mccreadie |